Trial · NCT03018249
Adverse events58
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
41 to 58 of 58
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pelvic Pain | Reproductive system and breast disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 2 | 23 | |
| other | Pelvic Pain | Reproductive system and breast disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 2 | 23 | |
| other | Vaginal Discharge | Reproductive system and breast disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Vaginal Discharge | Reproductive system and breast disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 4 | 23 | |
| other | Vaginal Hemorrhage | Reproductive system and breast disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Vaginal Hemorrhage | Reproductive system and breast disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 4 | 23 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 5 | 23 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Dyspnea | Respiratory, thoracic and mediastinal disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 5 | 23 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 2 | 23 | |
| other | Hypertension | Vascular disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | |
| other | Hypertension | Vascular disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 2 | 23 | |
| serious | Thromboembolic Event | Blood and lymphatic system disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 1 | 23 | 1 |
| serious | Thromboembolic Event | Blood and lymphatic system disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 1 | 23 | 1 |
| serious | Skin infection | Skin and subcutaneous tissue disorders | Arm I (Medroxyprogesterone Acetate, Hysterectomy) MPA | 0 | 23 | 0 |
| serious | Skin infection | Skin and subcutaneous tissue disorders | Arm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat | 1 | 23 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03018249/events?page=3